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Tamm-Horsfall protein (TH protein), a renal epi-
thelial glycoprotein, was isolated originally from
human urine [1, 2]. This membrane glycoprotein
has several unusual physicochemical character-
istics that may determine its role in normal tubular
function in its distal nephron site of synthesis and in
pathologic conditions. Variations of the ionic envi-
ronment in the physiologic ranges observed in urine
or within the kidney cause remarkable changes in
the physical properties of TH protein. These revers-
ible changes are the basis for the standard method
of TH protein isolation and purification by repeated
precipitations in 0.58 M sodium chloride solution
and dialysis against distilled water, originally de-
scribed by Tamm and Horsfall [1, 2]. Increasing
concentrations of TH protein, electrolytes, or hy-
drogen ions within physiologic limits causes aggre-
gation of TH protein molecules, leading to in-
creased viscosity and gel formation [3, 4]. When
these conditions are met within the nephron, hyal-
me casts are formed. TH protein is the primary con-
stituent of hyaline casts, according to immuno-
chemical [5, 6] and biochemical composition [6] and
immunofluorescent microscopy [7, 8]. McQueen
first established that the matrix of casts was pre-
dominantly TH protein by showing that hyaline
casts from a nephrotic patient contained 50 times
more TH protein than they did albumin [5]. More
than two decades before the classical isolation by
Tamm and Horsfall [I], a remarkable description of
the solubility characteristics of TH protein was pro-
vided by Thomas Addis [9]:
The casts in urine . . . are composed of a substance which
dissolves as the hydrogen ion concentration and the salt
concentration of the urine fall . . . Advantage may be taken
of this property of hyaline casts to separate the substance of
which they are composed from the other formed and un-
formed urinary constituents. . . If the urine is drawn off and
replaced by 0.9 percent NaCI solution the hyaline casts are
still preserved. The addition of a slight excess of NH4 OH
will dissolve them and now on centrifuging, the supernatant
salt solution contains the hyaline cast material. The addition
of a certain amount of acetic acid precipitates the material in
an amorphous gelatinous form which may be centrifuged
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off, redissolved in salt solution made alkaline with NH4OH
and reprecipitated as often as is necessary to effect practi-
cally a complete separation from the urine.
Addis wrote subsequently concerning cast forma-
tion [10],
If the dissolved material of which the hyaline casts were
composed is sufficiently concentrated and we add salt to
make the concentration 0,5% or more and acetic acid until
the pH is 5 or less, we shall find that what happened in the
tubules when the hyaline casts were formed will happen
again in the centrifuge tube. As the reaction changes from
alkaline to acid there is a sudden gelling of the fluid and the
tube is now full of a transparent mold that is a cast of its
lumen. This is the pure hyaline cast without visible structure
or content. But it is obvious that if before putting in the acid,
we had added red blood cells, epithelial cells. . . to the solu-
tion, they would have been caught as they floated in the fluid
when the gel formed and we should have found them embed-
ded within the cast. Thus, there are as many variations of
hyaline casts as there are differences in the content of the
fluid in the tubule at the moment the casts are found.
Recent studies have given new information con-
cerning the biochemical characteristics and mor-
phologic localization of TH protein and indicate
that this protein may be involved in the pathogene-
sis of renal diseases. In this review, these studies
will be analyzed in the context of current under-
standing of the physiology of the nephron segment
that produces TH protein.
Biochemicalfeatures
Although human TH protein has been the most
extensively studied, it has also been isolated from
the urine of other species by similar methods [11—
15], and immunologic cross-reactivity has allowed
identification of TH protein in the kidneys of further
species by immunofluorescent microscopy [11—16].
Aggregates of TH protein over a broad range of
molecular weights, which may exceed 7 x l0 dal-
tons [2], are present in dilute salt solutions. In elec-
tron micrographs, TH protein is seen as unbranched
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filaments of variable length with a regular zig-zag
appearance [6, 17-19]. The appearance of these fila-
ments suggests a helical organization; circular di-
chroic spectroscopy indicates a /3-structure [17]. In
more concentrated salt solution, the long filaments
appear to show lateral association into bundles [18],
whereas after treatment with dissociating agents,
the linear array is disrupted into numerous discrete
particles [6, 17]. Human TH protein may be dis-
sociated into molecular-weight subunits of approxi-
mately 100,000 daltons by several agents including 6
M guanidine, 50% acetic acid, and sodium dodecyl
sulfate [20—22], a subunit size consistent with mini-
mal molecular weight estimated by cyanogen bro-
mide cleavage studies [22]; subunits of rabbit and
hamster TH proteins treated with sodium dodecyl
sulfate have similar molecular weights [14, 15].
The TH proteins isolated from human, rabbit,
and hamster urine and analyzed under similar con-
ditions show no appreciable differences in the rela-
tive proportions of the amino acid components [14,
15, 23]. No unusual amino acids have been detect-
ed, and the most notable feature is an extremely
high content of 1/2 cystine residues relative to other
glycoproteins. Analyses of the /2 cystine content of
human TH protein after performic acid oxidation to
cysteic acid and after reduction and alkylation are
in close agreement [20, 21, 23] and indicate that
each molecular subunit (100,000 daltons) of TH pro-
tein contains approximately 50 residues of 1/2 cys-
tine. All of these 1/2 cystine residues appear to be
involved in intrachain disulfide bonds because re-
duction of these disulfide bonds with mercaptoetha-
nol or reduction and alkylation of these residues did
not dissociate TH protein into smaller subunits [20,
22, 23], and free thiol units were not detected [23].
A remarkably high '/2 cystine is also present in TH
proteins of the rabbit [14], hamster [15], and rat
(Hoyer, unpublished observations); these /2 cys-
tine residues are also involved in intrachain disul-
fide bonds [14]. Such extensive intramolecular
cross-linkage by disulfide bonds is an unusual fea-
ture and should cause considerable rigidity in the
structure of TH protein subunits.
In contrast to very similar amino acid composi-
tions of TH proteins from different species, TH pro-
teins, like other glycoproteins, vary considerably in
the carbohydrate components which constitute
nearly 30% of the protein by weight [14, 15, 20, 23].
For example, it is now apparent that inhibition of
viral hemagglutination, the basis for Tamm and
Horsfall's original isolation of this protein from hu-
man urine [1, 2], is related to its content of approxi-
mately 5% sialic acid by weight but is not an in-
variable feature. Because hamster TH lacks sialic
acid [15] and the sialic acid of rabbit TH protein is
O-acetylated [24], inactivity of these proteins in
hemagglutination reactions [25] appears related to
these compositional differences.
Although many structural aspects have not been
defined, the reversible aggregation and gel-forming
properties of TH protein appear related to its un-
usual biochemical composition. Aggregation of TH
protein as pH is lowered is the expected con-
sequence of the very low isoelectric point [1, 27]
resulting from the combination of a high content of
sialic acid [20, 23] and an excess of acidic over basic
amino acids [23]. By analogy to other glycopro-
teins, including those of the gastrointestinal tract,
which have been particularly studied in this regard
[28], the viscous and gel-forming properties of TH
protein appear related to the carbohydrate side
chains, which may interact with water, electrolytes,
and other glycoprotein molecules with compatible
geometry. The reversibility of aggregation of TH
protein indicates that intermolecular associations
are of the fleeting type characteristic of entropically
favorable interactions between rigid molecular
structures" [29]. In this regard, rigidity of TH pro-
tein subunit structure may be reasonably predicted,
based on the extensive intramolecular cross-linkage
by disulfide bonds.
Increased viscosity and gel formation in dilute so-
lutions of TH protein results from the addition of
very low concentrations of calcium chloride (6 to 7
mM [26, 30] or sodium chloride (60 mM) [30]. The
effects of these divalent and monovalent cations are
additive, dependent on glycoprotein concentration
[30] and inhibited by removal of sialic acid [17]. It is
of note that increasing concentrations of urea de-
crease viscosity and increase the solubility of TH
protein in salt solutions [31]. Serum proteins also
influence the behavior in solution of TH protein.
For example, albumin alters the electrophoretic
mobility of TH protein and decreases movement of
TH protein in immunodiffusion analysis [25], prob-
ably on the basis of aggregate formation.
The physiologic role of TH protein may be re-
lated to the distinctive physicochemical character-
istics described, since the concentrations involved
in these interactions are within the ranges encoun-
tered within the kidney. Evidence for the renal ori-
gin of TH protein has included immunochemical
identification of TH protein in urine produced by
isolated perfused kidneys [13] and from hamster
kidney cells grown in culture [15, 25].
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Fig. 1. Normal perfusion-fixed rat kidney showing extension of
low cuboidal epithelium of cortical ascending thick limb of
Henle's loop (ALH) beyond the macula densa (MD) of the par-
ent glomerulus and abrupt transition to the taller epithelium of
the distal convoluted tubule (DCT). The direction of urine flow is
indicated by an arrow. (Hematoxylin and eosin stain; x375)
Morphologic localization
The results of recent physiologic and morpholog-
ic studies have led to modification of previous con-
cepts of the segmental organization of the distal tu-
bule [32—40]. Features of the initial portion, the
thick ascending limb of the loop of Henle (ALH),
will be emphasized in this discussion, since TH pro-
tein is primarily localized in this segment. Accord-
ing to traditional definition, the ALH ends at the
macula densa, and the distal convoluted tubule
(DCT) extends from the macula densa to the first
junction with another tubule. Ultrastructural evi-
dence, however, that the morphologic transition
from the ALH to DCT in the rat occurs beyond the
macula densa has been provided recently by Allen
and Tisher [38] and by Kaissling, Peter, and Kriz
[39]. The latter findings confirm the description in
1909 by Peter [41] of transitions from the relatively
thin-walled cortical ALH to thick-walled distal con-
voluted tubules at variable short distances beyond
the macula densa based on his studies of isolated
tubules from several species. Observations made
during our recent studies of the ultrastructural lo-
calization of TH protein [42] and of immune depos-
its in kidneys of rats immunized with autologous
TH protein [43, 44] also indicate that this morpho-
logic transition occurs beyond the macula densa
(Fig. 1). A variable length of relatively flat epithe-
hum characteristic of the cortical ALH always sep-
arates the columnar DCT epithehial cells from the
macula densa. Although it is occasionally possible
to recognize such transitions in conventional histo-
logic preparations, favorable longitudinal sections
allowing such an identification are much more fre-
quently encountered in semi-thin sections of per-
fused-fixed kidneys.
Previous immunofluorescent reports indicate that
TH protein is exclusively localized in renal tissue
and have described staining for TH protein in cells
of the ALH, the macula densa region, and the distal
convoluted tubule [11, 12, 45], based on traditional
morphologic definitions of the distal tubular seg-
ments. In view of revised morphologic limits de-
scribed above, we have recently reevaluated the im-
munofluorescent localization of TH protein in con-
junction with ultrastructural studies [42, 44] with
particular emphasis on the region of the macula
densa. In agreement with previous immuno-
fluorescent descriptions, positive staining reactions
for TH protein in the tubular cytoplasm outlining
luminal and basal cell borders and nuclei were ob-
served in the ALH. In the initial outer medullary
portion of the ALH, cytoplasmic staining in the rel-
atively tall cells of the inner stripe appeared concen-
trated toward the luminal surface, whereas in the
later ALH, staining appeared more evenly distrib-
uted between basal and luminal regions. In sections
through the juxtaglomerular apparatus, the macula
densa cells were negative in contrast to the strongly
positive staining for TH protein of tubular cells on
the opposite side of the tubular lumen. Positive
staining for TH protein similar to that in the earlier
cortical ALH was seen in the short tubular segment
immediately distal to the macula densa, whereas
staining of tubular cells after transition to the taller
columnar epithehium of the DCT was confined to
the luminal border. TH protein was not detected by
immunofluorescent microscopy in glomeruli, proxi-
mal tubules, thin loops of Henle, collecting ducts,
or transitional epithehium of rat kidney (Fig. 2). This
immunofluorescent distribution of TH protein was
identical to that observed by light microscopy using
peroxidase labeled antibodies to TH protein and
frozen sections and semi-thin (0.5 t) sections of tis-
sue processed for immunoelectron microscopy [42].
The precise identification of tubular cells in the jux-
taglomerular region permitted by the use of these
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Fig. 2. Irnmunofluorescent localization of THprotein in normal rat renal cortex near fornix. ALH cells show a bright cytoplasmic pattern
of fluorescence; staining in distal convoluted tubule (arrow) is luminal. Note absence of staining in proximal tubules, glomeruli (G) and in
the transitional urinary epithelium (area between asterisks). (X200)
latter sections was crucial in determining absence of
TH protein in macula densa cells, a finding of poten-
tial physiologic importance not previously noted.
TH protein was demonstrated by immunoelectron
microscopy along the basal, lateral, and luminal
surface membranes of ALH cells and also in the
Golgi region, providing ultrastructural evidence for
the synthesis of this surface membrane protein in
these cells [42]. In contrast, TH protein was found
only on the luminal surface of macula densa cells
and tubular cells distal to the ALH; this probably
reflects adsorption related to urinary excretion of
TH protein. The renal localization of immune com-
plexes in rats immunized with autologous TH pro-
tein [43, 44] supports the above description of TH
protein in normal kidneys. IgG and TH deposits at
the base of ALH cells in the inner stripe were less
numerous and smaller than those in ALH cells in
the outer stripe and cortex, corresponding to less
basal staining for TH protein in the first portion of
the ALH in normal kidneys compared to that in the
later ALH. A conspicuous absence of immune de-
posits at the base of macula densa cells and pres-
ence of these deposits in adjacent ALH cells corre-
spond closely with the normal cellular distribution
of TH protein in this region. Ontogenetic studies
have demonstrated TH protein in human and rat fe-
tal kidneys [12, 16] and indicate that presence of
this protein is closely related to development of the
ALH [12].
Physiology of ascending thick limb of Henle's loop
Because the tubular distribution of TH protein
precisely corresponds to revised morphologic limits
of the ALH based on ultrastructural features, this
protein may be a useful antigenic marker for this
nephron segment. Furthermore, TH protein may
have an important functional role in the ALH.
Because the ALH is not accessible to micro-
puncture, our current understanding of the physio-
logic characteristics of this segment has been de-
rived largely from recent in vitro studies of isolated
perfused rabbit tubules [32-35]. The reabsorption
by the ALH of a large fraction of the sodium chlo-
ride in the glomerular ultrafiltrate is the con-
sequence of active transport of chloride ions [32,
33]. Net water flux measurements in these studies
indicate that permeability of the ALH to water is
extremely low compared to that of isolated rabbit
proximal tubules [32, 33]. This impermeability to
water, in conjunction with active chloride trans-
port, allows generation and delivery to the distal
convoluted tubule of a tubular fluid which is hypo-
tonic to plasma. Separation of solute from water in
the ALH is critically important in generating and
maintaining the medullary concentration gradients
upon which the countercurrent multiplier system is
based [46].
Considerable progress has been made during the
past decade in defining the water permeation char-
acteristics of the nephron segments involved in the
countercurrent multiplier system under various
conditions, and morphologic techniques have been
helpful in defining pathways for water movement
[36]. Tight junctions between ALH cells were pene-
trated, however, by lanthanum, and "tight" tightjunctions similar to those observed in other epi-
thelia would not appear to be responsible for the
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impermeability to water crucial to the function of
this segment [46].
Functional effects of the unusual physical proper-
ties of TH protein are of interest because of the
unique surface membrane localization of this pro-
tein in the ALH. Potential influences on the per-
meability characteristics of this segment will be
onsidered here. Aggregation of TH protein leading
to increased viscosity and gel formation in vitro is
promoted by increasing the concentration of elec-
trolytes within the physiologic ranges. Therefore,
the physical state of the TH protein molecules asso-
ciated with luminal, lateral, and basal cell surface
membranes of the ALH should show topographic
variation based on differences in ionic environment.
Thus, the extent of TH protein aggregation along
basal cell surfaces would be considerably greater
than it is on luminal ALH membranes, based solely
on differences in tubular lumen and plasma concen-
trations of sodium chloride, particularly in the later
ALH. Other factors also promote aggregation of
TH protein molecules at the basal surface of ALH
cells, most notably, plasma proteins normally pres-
ent in the extravascular space consequent to the
limited permselectivity of peritubular capillaries
[47]. Although the complex apical lateral inter-
digitations of ALH cells [38] allow this segment to
be distinguished by scanning electron microscopy
from the distal convoluted tubule [46], the ionic en-
vironment of the lateral intercellular spaces of the
ALH is undefined at present. Because inhibition of
active chloride transport in isolated ALH segments
perfused with ethacrynic acid or furosemide or with
mercurial diuretics was remarkably greater than
were the effects with these drugs in the bath [35],
action appears to be at or near the luminal surface.
Although the precise molecular mechanisms and
cellular site of active chloride transport are un-
known [35], these pharmacologic studies are com-
patible with a chloride pump" located in lateral
membranes near the cell apex. Active chloride
transport (and passive movement of cations) into
the lateral intercellular spaces would create an ionic
environment favorable to aggregation of the TH
protein molecules present on the lateral inter-
cellular membranes. If this process occurs near the
cell apex, an intercellular ionic environment com-
parable to that on basal surfaces could be present
along the entire lateral space. The considerable dai-
ly urinary TH protein excretion of approximately 50
mg by normal adult humans [48, 49] suggests that
TH protein molecules of ALH surface membranes
are not bound so tightly as to prevent interactions
with other TH protein molecules, including those of
the opposing lateral membranes. Thus, the entire
lateral intercellular space could contain TH protein
in an aggregated state. The diffusion characteristics
within this space would tend to reach a steady state
with regard to water, because any diffusion of water
out of this space into plasma would quickly shift the
equilibrium further toward aggregation of TH pro-
tein. This would further restrict inward water move-
ment and thus oppose osmotic forces. Passive dif-
fusion of ions would also be restricted in such a TH
protein gel, and electrolyte movement would be al-
most entirely on the basis of active chloride trans-
port. The experimentally observed greater per-
meability of the ALH to sodium than to chloride
[32] may be related to the net negative charge on
TH protein under physiologic conditions. The bio-
synthetic energy cost of maintaining TH protein as
a surface glycoprotein in the ALH is considerable,
as reflected in the high rate of urinary excretion [48,
49] and the rapid turnover (half life of 9 hours in the
rabbit) [50]. Urinary excretion almost certainly re-
flects, at least in part, solubilization of TH protein
from luminal membranes, because in the steady
state, sodium chloride concentration in the lumen of
the isolated ALH [32] is close to the minimal con-
centration (60 mM) required for gel formation in vi-
tro [30]. The unique electrolyte-dependent revers-
ible aggregation of TH protein, however, appears to
allow considerable overall economy in the ALH,
because the presence of TH protein allows the chlo-
ride pump to be a driving force for both ion move-
ment and the permeability characteristics of this
segment.
In considering the role of TH protein in per-
meability characteristics of the ALH, the absence
of TH protein in macula densa cells appears to be a
critical observation; the efficiency of tubulo-
glomerular feedback mechanisms based on elec-
trolyte concentration in tubular fluid presented to
macula densa cells [51] would appear to be greater if
the permeability characteristics of these cells dif-
fered from those in the ALH.
Ta,nm-Horsfall protein in pathologic states
Within the conceptual framework provided
above, it is possible to examine further not only the
contribution of TH protein to nephron function, but
also the participation of this unique renal membrane
glycoprotein in disease pathogenesis. The in-
volvement of TH protein in disease states may be
discussed conveniently in terms of four interrelated
categories: rates of excretion, formation of urinary
casts, pathologic tissue localization, and immuno-
logic responses to TH protein.
Although the rate of urinary TH protein excretion
of normal individuals appears to be fairly constant
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[48, 49] and to be decreased in proportion to de-
creases in GFR in most patients with chronic renal
failure [48, 49], the tendency toward aggregation
and interaction with other proteins has complicated
quantitation. Thus, recent attention in quantitation
has been directed primarily toward methodology
[52-57] rather than toward study of pathologic
states, with a few noteworthy exceptions. Although
patients with renal failure secondary to cadmium
nephropathy or the Fanconi syndrome had de-
creased creatinine clearances, TH protein excretion
by these patients was normal, indicating increased
TH protein excretion relative to GFR. Increased
TH protein excretion has been reported in the ne-
phrotic syndrome [48], although no direct correla-
tion with excretion of serum proteins was observed.
These observations taken together suggest that an
increase in TH protein excretion might be related to
increased sodium chloride delivery to the distal tu-
bule secondary to the nephrotic syndrome, as pre-
viously suggested [58], or to proximal tubular dys-
function in the Fanconi syndrome and cadmium ne-
phropathy. Transient increased excretion of TH
protein has been reported also to be a consequence
of acute renal tubular injury produced by potassium
dichromate [59] and in renal allograft rejection [60].
Additional studies will be required for confirmation
and clarification of mechanisms involved in TH pro-
tein excretion.
The factors leading to cast formation in a clinical
setting are primarily the summation of the factors
causing aggregation of TH protein and gel formation
in vitro; that is, increasing concentrations of hydro-
gen ions, electrolytes, and TH protein [3, 4]. Thus,
cast formation is observed in acidosis [61] and in
dehydration and oliguria related to severe exercise
[62, 63]. Although serum proteins in urine promote
aggregation of TH protein, the number of urinary
casts observed in the nephrotic syndrome corre-
lates best with reductions in urine flow [64]. Under
most circumstances, the concentrations required
for cast formation appear to be only temporarily
met in a small percentage of tubules, and these casts
are passed subsequently into the urine without diffi-
culty. Under extreme conditions, however, as in se-
vere dehydration and acute renal failure, larger
numbers of tubules may become filled with casts
composed primarily of TH protein, particularly in
regions of high osmolarity; that is, in the collecting
ducts of the renal papillae: A role for tubular ob-
struction by these TH protein casts in the develop-
ment and maintenance of renal failure has been sug-
gested [65]. It should be noted that cast formation in
the renal medulla is normally opposed by factors fa-
voring disaggregation, such as high concentrations
of urea [31]. Given such a balance, superimposing
additional factors not normally present in tubular
fluid has the potential for shifting the equilibrium
markedly toward aggregation of TH protein and
cast formation. For example, in vitro interactions
with TH protein have been observed in studies of
radiographic contrast media [65] and with hemoglo-
bin, myoglobin, and Bence Jones protein [5, 67]; in-
teractions of these proteins with TH protein were
promoted by lowering pH within the urinary range.
Because development of acute renal failure in
multiple myeloma is relatively frequent [68], vari-
ous factors associated with precipitation of acute
renal failure in this disease will be considered here
with regard to their effect on TH protein cast forma-
tion. Often, several factors appear to be involved
including dehydration as a primary or secondary
feature promoting cast formation. Administration of
radiographic dyes has been associated frequently
with subsequent deterioration of renal function,
particularly in patients with prior dehydration [68,
69]. Thus, avoiding dehydration prior to intra-
venous pyelography in patients with multiple
myeloma or other patients particularly susceptible
to dehydration, such as infants, has been appropri-
ately encouraged [68, 69]. The physical properties
of individual Bence Jones proteins are important
determinants in cast formation; proteins derived
from patients with cast nephropathy have caused
distal tubular cast formation when injected into mice
and rats [70, 71]. Aciduric, hydropenic rats injected
with Bence Jones proteins showed acute elevations
of blood urea nitrogen if the isoelectric point of the
injected protein was higher than urinary pH [71]. In-
teractions of Bence Jones proteins with TH protein
[67] and cast formation are favored by such condi-
tions and may contribute to the severity of renal le-
sions, either as primary or, as suggested [70], as
secondary events.
Hypercalcemia was the factor most frequently as-
sociated with development of acute renal failure in
the large multiple myeloma series of DeFronzo et al
[68]. Hypercalcemia may be etiologically involved
in cast formation, both by primary interactions with
TH protein, which occur at very low concentrations
[26, 30], and by secondary effects, such as decreas-
ing the GFR [72] and enhancing dehydration [68].
Although a precise relationship to the nephrotoxici-
ty of hypercalcemia has not been defined, the bind-
ing of calcium and hydrogen ions to TH protein [26]
on cell surface membranes would be expected to in-
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fluence not only ion transport in the ALH, but also
toxicity. It is noteworthy that early destructive re-
nal lesions of hypercalcemia and hypercalcuria tend
to occur in collecting ducts and the ALH [73],
segments with high TH protein concentrations in
tubular fluid or on cell surface membranes, respec-
tively. Thus, several factors associated with the de-
velopment of acute renal failure in multiple myelo-
ma promote TH protein aggregation and cast forma-
tion. Definition of such relationships is basic to
effective therapeutic strategies in this disease and
other forms of acute renal failure involving cast for-
mation.
Interest in a potential role in stone formation
stimulated early studies of TH protein. The quan-
tities of TH protein in urinary calculi, however, are
extremely variable [49], and an etiologic relation-
ship has not been established.
Although the major pathogenetic contribution of
intratubular TH protein appears to be tubular ob-
struction by urinary casts, disruption of tubular in-
tegrity and urinary extravasation may lead to addi-
tional pathogenetic roles. Osmotic removal of water
from extravasated urine greatly facilitates the pre-
dictable conversion of soluble urinary TH protein
into insoluble extratubular aggregates. Extratubular
TH protein deposits, once formed, may persist for
prolonged periods and provide an excellent antigen-
ic marker for urinary extravasation. Three inde-
pendent reports [74-76] using a common antiserum
to TH protein have recently demonstrated extra-
tubular TH protein deposition in human renal dis-
ease; deposits were detected most frequently in
medullary cystic disease, obstructive uropathy with
vesicoureteral reflux, chronic pyelonephritis, and in
other forms of tubulointerstitial nephritis. Entrap-
ment of TH protein occurred predominantly within
the renal interstitium (Fig. 3), although TH protein
was also seen in venous poiyps, and some deposits
appeared to be within lymphatics [74-76]. Accumu-
lations of inflammatory cells surrounded some of
the interstitial TH protein masses and may reflect a
reaction to these TH protein deposits. An experi-
mental model of human obstructive uropathy with
vesicoureteral reflux (reflux nephropathy) has been
produced in pigs by Hodson et al [77, 78]. In this
model, interstitial deposits of TH protein similar to
those seen in human renal tissue are present [79],
and autoantibodies to TH protein are described
[77].
Until recently, TH protein was considered to be a
sequestered cytoplasmic renal tubular antigen, not
normally accessible to the immune system. Because
Fig. 3. Interstitial deposits of TH protein extending around a di-
lated tubule in renal biopsy specimen from a patient with medul-
lary cystic disease. In this section from near the corticomedul-
lary junction, numerous ALH's show cytoplasmic staining.
(Antihuman TH protein; x 160)
TH protein has been shown, however, to be a sur-
face membrane glycoprotein [42] in direct contact
with the extravascular space, and the associated
peritubular capillaries are permeable to macromole-
cules [47], this concept of sequestration deserves
reevaluation. In this regard, aggregation of TH pro-
tein in the extravascular space would still greatly
restrict movement of this protein across peritubular
capillaries. Aggregation would also probably pre-
vent prolonged circulation of more than minute
quantities of TH protein in plasma. Although TH
protein had not been detected previously in serum,
extremely small quantitites (nanograms per millili-
ter) of material that reacted similarly to TH protein
in a radioimmunoas say were reported recently to be
present in normal human serum [56].
Immunologic reactions to TH protein have been
documented in human diseases. Children with acute
pyelonephritis were reported to have serum IgG
antibodies to TH protein [80], and cell-mediated im-
munity to TH protein has been described in patients
with chronic liver disease and associated renal
tubular acidosis [81]. Autoantibodies binding to epi-
thelium of the cortical ALH and distal tubules have
been detected by indirect immunofluorescence in
the sera of patients with disorders of presumed im-
mune etiology, including some with renal tubular
acidosis [82-84], and some of these may be anti-
bodies to TH protein. In contrast, deposition of im-
munoglobulin and inflammatory cell responses have
not been associated regularly with extratubular TH
protein deposits [74, 75]. Despite increasing evi-
dence concerning the presence of immune re-
sponses to TH protein in human renal diseases,
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clarification of the pathogenetic role of these re-
sponses remains a goal for future studies.
The possibility that presence of TH protein on
surface membranes of the ALH in the juxtaglo-
merular region might be a factor in the mesangial
transport pathway has been raised by recent stud-
ies. Movement of macromolecules from the gb-
merular mesangium to the nontubular cells of the
juxtaglomerular apparatus occurs along a pathway
that has both morphologic [85] and functional [86-
89] continuity. Recent evidence indicating exten-
sion of this pathway to the distal tubule has been
provided by ultrastructural tracer studies using an
iron-dextran complex in normal mice [83] and by
immunohistologic studies of diabetic mice [84], and
it has been proposed that particles are then dis-
charged into the tubular lumen [83]. During the au-
tologous phase of nephrotoxic serum nephritis in
rats, 1gM deposits extending from the gbomerular
mesangium to the base of juxtagbomerular ALH
cells may be seen (Fig. 4). Dual label (fluorescein
and rhodamine) immunofluorescence with antirat
TH protein and antirat 1gM on the same frozen sec-
tions aided identification of tubular cells with basal
1gM deposits as ALH cells (Hoyer, unpublished ob-
servations). Thus, a similar mesangial pathway to
the distal tubule also appears to operate in immune-
mediated glomerulonephritis.
The renal lesions produced in rats immunized
with autologous TH protein have been studied in
our laboratories [43, 44] to define the pathogenetic
potential of immune responses to this tubular anti-
gen. In this new experimental model of tubulo-
interstitial nephritis, granular and nodular deposits
of IgG, C3, and TH protein are localized at the base
of ALH cells. Ultrastructural analysis has shown
that the earliest deposits are subepithelial and pres-
ent between basal cell membrane infoldings and the
tubular basement membranes of the ALH. In more
severe lesions, larger electron dense deposits be-
tween tubular cell membranes and within tubular
basement membranes distorted tubular archi-
tecture. Focal tubular necrosis and infiltration of
mononuclear and polymorphonuclear leukocytes
were seen in occasional destructive lesions. Sera
samples of these immunized rats with basal ALH
deposits of IgG and TH protein contained high titers
of IgG antibodies to TH protein by indirect immu-
nofluorescence. In view of ALH peritubular capil-
lary permeability to macromolecules [47] and the
absence of gbomerular and luminal ALH deposits, it
is likely that basal ALH deposits in this model are
the consequence of antibodies to TH protein cross-
Fig. 4. Granular deposits of rat 1gM in glomerular mesangiu,n
extending to the base qfALH cells opposite the vascular pole in
rat with nephrotoxic serum nephritis. (x 375)
ing the tubular basement membrane and forming
complexes with TH protein molecules associated
with ALH cell surface membranes in situ. It has
been recently proposed that the glomerular local-
ization of subepithelial immune complexes in heter-
obogous immune complex gbomerulonephritis has a
similar pathogenesis involving in situ formation of
immune complexes [90].
Some rats vigorously immunized with whole rat
kidney by Klassen et al [91] showed several renal
lesions, including IgG deposits at the base of ALH
cells similar to those in our studies. The responsible
ALH antigen was not identified in their studies but
may have been TH protein. In view of evidence that
immune responses to TH protein also occur in hu-
man diseases, evaluation of their potential pathoge-
netic role should include consideration of factors
that may influence detection of basal ALH deposits.
Experimentally, the earliest and largest basal ALH
deposits are observed in the outer medulla and in-
ner cortex, and thus deposits could be missed in su-
perficial cortical sections. Furthermore, in later dis-
ease stages, staining may disappear, as has been
noted in antitubular basement membrane antibody
disease in rats [92]. Rat IgG deposits may be detect-
ed at the base of ALH cells for at least 6 months
after injection in rats actively immunized with TH
protein. Granular deposits of rabbit IgG in this site
in rats passively immunized with heterologous
antibody to rat TH protein are cleared, however,
within a month of injection [93]. Thus, subepithelial
immune deposits involving a tubular antigen in the
extravascular space of the ALH are cleared much
more rapidly than are the glomerular deposits formed
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after similar passive immunization of rats with
heterologous antisera to proximal tubular antigens.
These latter deposits may be detected several
months after injection {94, 95].
Although information concerning immune re-
sponses to TH protein is rapidly increasing, many
aspects of these responses remain to be defined.
These include the role of cell-mediated immunity,
the relationship between various forms of renal in-
jury and immune responses to TH protein, and the
functional effects of renal injury caused by these re-
sponses.
Summary
Tamm-Horsfall protein, a renal glycoprotein
present in normal urine, is the primary constituent
of urinary casts. Immunoelectron microscopy has
shown that this protein is localized selectively along
surface membranes of the thick ascending loop of
Henle. In this surface membrane site, the unique
aggregation and gel formation of Tamm-Horsfall
protein in response to increasing concentrations of
electrolytes within physiologic ranges may influ-
ence the permeability characteristics of this neph-
ron segment. These aggregation characteristics also
play a role in pathologic conditions and lead to the
prolonged persistence of interstitial Tamm-Horsfall
protein deposits in several tubulointerstitial dis-
eases. Recent studies have demonstrated immuno-
logic responses to this protein, including an immune
complex tubulointerstitial nephritis in rats mediated
by autoantibodies to Tamm-Horsfall protein.
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